These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 21932422)
1. Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. Gao Y; Katki H; Graubard B; Pollak M; Martin M; Tao Y; Schoen RE; Church T; Hayes RB; Greene MH; Berndt SI Int J Cancer; 2012 Jul; 131(2):E105-13. PubMed ID: 21932422 [TBL] [Abstract][Full Text] [Related]
2. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. Murphy N; Carreras-Torres R; Song M; Chan AT; Martin RM; Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Bradbury KE; Besevic J; Rinaldi S; Riboli E; Cross AJ; Travis RC; Agnoli C; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Onland-Moret NC; Burnett-Hartman A; Campbell PT; Casey G; Castellví-Bel S; Chang-Claude J; Chirlaque MD; de la Chapelle A; English D; Figueiredo JC; Gallinger SJ; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Ose J; Perduca V; Phipps AI; Platz EA; Potter JD; Qu C; Rennert G; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang H; White E; Wolk A; Woods MO; Wu AH; Zheng W; Peters U; Gunter MJ Gastroenterology; 2020 Apr; 158(5):1300-1312.e20. PubMed ID: 31884074 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study. Adachi Y; Nojima M; Mori M; Matsunaga Y; Akutsu N; Sasaki S; Endo T; Kurozawa Y; Wakai K; Tamakoshi A; Tumour Biol; 2016 Nov; 37(11):15125-15132. PubMed ID: 27662841 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like Growth Factor-1, Insulin-like Growth Factor Binding Protein-3 and the Incidence of Malignant Neoplasms in a Nested Case-Control Study. Adachi Y; Nojima M; Mori M; Himori R; Kubo T; Yamano HO; Lin Y; Wakai K; Tamakoshi A; Cancer Prev Res (Phila); 2020 Apr; 13(4):385-394. PubMed ID: 31996369 [TBL] [Abstract][Full Text] [Related]
5. Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma. Patel D; Ellis R; Howard B; Boufraqech M; Gara SK; Zhang L; Quezado MM; Nilubol N; Kebebew E Ann Surg Oncol; 2014 Oct; 21(11):3541-7. PubMed ID: 24833102 [TBL] [Abstract][Full Text] [Related]
6. Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3. Fowke JH; Matthews CE; Yu H; Cai Q; Cohen S; Buchowski MS; Zheng W; Blot WJ Endocr Relat Cancer; 2010 Mar; 17(1):51-60. PubMed ID: 19786462 [TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of insulin-like growth factor and insulin-like growth factor binding protein 3 and recurrent colorectal adenomas. Flood A; Mai V; Pfeiffer R; Kahle L; Rosen CJ; Lanza E; Schatzkin A Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1493-8. PubMed ID: 18559566 [TBL] [Abstract][Full Text] [Related]
8. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density. Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654 [TBL] [Abstract][Full Text] [Related]
9. Circulating insulin-like growth factor binding protein-3 and risk of gastrointestinal malignant tumors. Adachi Y; Nojima M; Mori M; Kubo T; Yamano HO; Lin Y; Wakai K; Tamakoshi A; J Gastroenterol Hepatol; 2019 Dec; 34(12):2104-2111. PubMed ID: 31158304 [TBL] [Abstract][Full Text] [Related]
10. Higher IGFBP3 is associated with increased incidence of colorectal cancer in older men independently of IGF1. Chan YX; Alfonso H; Paul Chubb SA; Ho KKY; Gerard Fegan P; Hankey GJ; Golledge J; Flicker L; Yeap BB Clin Endocrinol (Oxf); 2018 Feb; 88(2):333-340. PubMed ID: 29044573 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. ; Key TJ; Appleby PN; Reeves GK; Roddam AW Lancet Oncol; 2010 Jun; 11(6):530-42. PubMed ID: 20472501 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival. Cao Y; Lindström S; Schumacher F; Stevens VL; Albanes D; Berndt S; Boeing H; Bueno-de-Mesquita HB; Canzian F; Chamosa S; Chanock SJ; Diver WR; Gapstur SM; Gaziano JM; Giovannucci EL; Haiman CA; Henderson B; Johansson M; Le Marchand L; Palli D; Rosner B; Siddiq A; Stampfer M; Stram DO; Tamimi R; Travis RC; Trichopoulos D; Willett WC; Yeager M; Kraft P; Hsing AW; Pollak M; Lin X; Ma J J Natl Cancer Inst; 2014 Jun; 106(6):dju085. PubMed ID: 24824313 [TBL] [Abstract][Full Text] [Related]
14. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371 [TBL] [Abstract][Full Text] [Related]
15. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk. Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men. Teramukai S; Rohan T; Lee KY; Eguchi H; Oda T; Kono S Jpn J Cancer Res; 2002 Nov; 93(11):1187-94. PubMed ID: 12460458 [TBL] [Abstract][Full Text] [Related]
17. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia. Yamaji T; Iwasaki M; Sasazuki S; Tsugane S Int J Obes (Lond); 2012 Mar; 36(3):440-7. PubMed ID: 21673650 [TBL] [Abstract][Full Text] [Related]
18. A prospective study of plasma C-peptide and colorectal cancer risk in men. Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117 [TBL] [Abstract][Full Text] [Related]
19. IGF-I, IGF-II, IGFBP2, IGFBP3 and acid-labile subunit (ALS) in colorectal cancer patients before surgery and during one year follow up in relation to age. Sztefko K; Hodorowicz-Zaniewska D; Popiela T; Richter P Adv Med Sci; 2009; 54(1):51-8. PubMed ID: 19482725 [TBL] [Abstract][Full Text] [Related]
20. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]